Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Institute of Endocrinology, Metabolism, and Reproduction (IEMYR) is a Quito, Ecuador-based endocrinology and metabolic medicine organization associated with the long-running clinical and research work of Jaime Guevara-Aguirre. The entity appears to operate primarily as a medical practice and hormonal/diagnostic laboratory rather than as a venture-backed drug-development biotech company. IEMYR is best known in the scientific literature for its work on growth hormone insensitivity, especially Laron syndrome cohorts in Ecuador, and for related endocrinology, metabolism, and reproductive health research. Publicly available business directory data also indicate a commercial legal entity in Ecuador, Medicina Metabólica y de Crecimiento IEMYR S.A., operating in the medical and diagnostic laboratory sector. Because the available sources are sparse and partly indirect, IEMYR is best characterized as an active healthcare and clinical research organization rather than a pharma or biotech developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute of Endocrinology, Metabolism, and Reproduction.